Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging

NEW YORK, January 08, 2008 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company and Avista Capital Partners, a leading private equity firm, announced today that Avista has completed its acquisition of Bristol-Myers Squibb Medical Imaging, a business unit of Bristol-Myers Squibb. Bristol- Myers Squibb Medical Imaging is a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures.

Based in Billerica, Massachusetts, Bristol-Myers Squibb Medical Imaging provides medical imaging products primarily focused on cardiovascular diagnostic imaging to nuclear physicians, cardiologists, radiologists, internal medicine physicians, IDNs/GPOs and technologists/sonographers working in hospitals and outpatient clinics. The company supplies its products to hospitals, clinics and radiopharmacies in the U.S., as well as internationally in certain countries including Australia and Canada.

J.P. Morgan Securities Inc. served as financial advisor for Bristol-Myers Squibb and Cravath, Swaine & Moore LLP served as its legal counsel. Weil, Gotshal & Manges served as legal counsel for Avista Capital Partners.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life. For more information, please visit www.bms.com.

About Avista Capital Partners

Avista Capital Partners is a leading private equity firm with offices in New York, NY and Houston, TX. Founded in 2005, Avista's strategy is to make controlling or influential minority investments primarily in growth-oriented media, healthcare and energy companies. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses. For more information, visit www.avistacap.com.

CONTACT: Media, Pete Paradossi, Communications, +1-812-429-7413,, or Jeff Macdonald, Communications, +1-212-546-4824,, or Investors, John Elicker, Investor Relations,+1-212-546-3775, , all of Bristol-Myers Squibb; Media,Diana Postemsky, Kekst and Company, +1-212-521-4805,, for Avista pete.paradossi@bms.com jeffrey.macdonald@bms.com john.elicker@bms.com diana-postemsky@kekst.com

Web site: http://www.bms.com/http://www.avistacap.com//

Ticker Symbol: (NYSE:BMY)

Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: January 2008


View comments

Hide
(web2)